Page 1 of 79
2025/2026 NEW MSN 611 ACTUAL PRACTICE
EXAM QUESTIONS AND ANSWERS NEW
MODIFIED VERSION TESTED AND
APPROVED!!
What is the function of plasmin?
a. Inhibits platelet cyclooxygenase
b. Inhibits cyclic GMP phosphodiesterase activity
c. Breaks cross-links between fibrin molecules
d. Converts fibrin to fibrinogen -- ANSWER--c. Breaks cross-links between
fibrin molecules
The best way to increase HDL levels is through:
a. statin therapy.
b. niacin supplementation
c. exercise.
d. fibric acid derivatives -- ANSWER--c. exercise
Choose the correct statement regarding heart failure.
,a. Less complicated symptoms occur in heart failure with reduced ejection
fraction (HFrEF) than in heart failure with preserved ejection fraction
(HFpEF)
b. Evidence-based treatments are available to decrease morbidity and mortality
for patients with HFrEF but not for patients with HfpEF.
c. Hydralazines should be avoided for African Americans.
d. Loop diuretics reduce morbidity but not mortality for patients with HFrEF. --
ANSWER--b. Evidence-based treatments are available to decrease morbidity
and mortality for patients with HFrEF but not for patients with HfpEF.
Which of the following statements accurately describes digoxin?
a. It is widely used to augment cardiac output.
b. It is broken down by the liver.
c. It increases ventricular contraction by activating the AV node.
d. Side effects can be reduced by using transdermal administration. --
ANSWER--d. Side effects can be reduced by using transdermal
administration
In the sequential thrombin amplification process, activated thrombin induces
production of:
a. prothrombin
, Page 3 of 79
b. antithrombin.
c. fibrin.
d. plasmin. -- ANSWER--c. fibrin.
Which step in the clotting cascade allows prothrombin to be converted to
thrombin?
a. Activation of factor IX to factor X
b. Activation of factor X to factor Xa
c. Activation of factor XI to factor XIa
d. Activation of factor XII to factor XIIa -- ANSWER--b. Activation of factor X
to factor Xa
What effects do cholinesterase inhibitors have on the sinoatrial and
atrioventricular nodes?
a. Vasovagal
b. Vagotonic
c. Somatic
d. Tachycardic -- ANSWER--b. Vagotonic
How do "mixed acting" sympathomimetic drugs work?
, a. They simultaneously activate release of norepinephrine and epinephrine.
b. They directly activate release of norepinephrine while also indirectly
inhibiting release of epinephrine.
c. They directly activate the release of norepinephrine while also directly
activating release of dopamine.
d. They directly activate the release of norepinephrine while also indirectly
causing a release of norepinephrine. -- ANSWER--d. They directly activate
the release of norepinephrine while also indirectly causing a release of
norepinephrine.
For which disease are GABA-derivative antispasmotic agents used effectively to
control muscle spasm?
a. Muscular dystrophy
b. Parkinson's disease
c. Multiple sclerosis
d. Huntington's disease -- ANSWER--c. Multiple sclerosis
What is the FDA-approved use for belladonna?
a. Moderate to severe pain associated with ureteral spasm not responsive to
nonnarcotic analgesics
b. Irritable bowel syndrome
2025/2026 NEW MSN 611 ACTUAL PRACTICE
EXAM QUESTIONS AND ANSWERS NEW
MODIFIED VERSION TESTED AND
APPROVED!!
What is the function of plasmin?
a. Inhibits platelet cyclooxygenase
b. Inhibits cyclic GMP phosphodiesterase activity
c. Breaks cross-links between fibrin molecules
d. Converts fibrin to fibrinogen -- ANSWER--c. Breaks cross-links between
fibrin molecules
The best way to increase HDL levels is through:
a. statin therapy.
b. niacin supplementation
c. exercise.
d. fibric acid derivatives -- ANSWER--c. exercise
Choose the correct statement regarding heart failure.
,a. Less complicated symptoms occur in heart failure with reduced ejection
fraction (HFrEF) than in heart failure with preserved ejection fraction
(HFpEF)
b. Evidence-based treatments are available to decrease morbidity and mortality
for patients with HFrEF but not for patients with HfpEF.
c. Hydralazines should be avoided for African Americans.
d. Loop diuretics reduce morbidity but not mortality for patients with HFrEF. --
ANSWER--b. Evidence-based treatments are available to decrease morbidity
and mortality for patients with HFrEF but not for patients with HfpEF.
Which of the following statements accurately describes digoxin?
a. It is widely used to augment cardiac output.
b. It is broken down by the liver.
c. It increases ventricular contraction by activating the AV node.
d. Side effects can be reduced by using transdermal administration. --
ANSWER--d. Side effects can be reduced by using transdermal
administration
In the sequential thrombin amplification process, activated thrombin induces
production of:
a. prothrombin
, Page 3 of 79
b. antithrombin.
c. fibrin.
d. plasmin. -- ANSWER--c. fibrin.
Which step in the clotting cascade allows prothrombin to be converted to
thrombin?
a. Activation of factor IX to factor X
b. Activation of factor X to factor Xa
c. Activation of factor XI to factor XIa
d. Activation of factor XII to factor XIIa -- ANSWER--b. Activation of factor X
to factor Xa
What effects do cholinesterase inhibitors have on the sinoatrial and
atrioventricular nodes?
a. Vasovagal
b. Vagotonic
c. Somatic
d. Tachycardic -- ANSWER--b. Vagotonic
How do "mixed acting" sympathomimetic drugs work?
, a. They simultaneously activate release of norepinephrine and epinephrine.
b. They directly activate release of norepinephrine while also indirectly
inhibiting release of epinephrine.
c. They directly activate the release of norepinephrine while also directly
activating release of dopamine.
d. They directly activate the release of norepinephrine while also indirectly
causing a release of norepinephrine. -- ANSWER--d. They directly activate
the release of norepinephrine while also indirectly causing a release of
norepinephrine.
For which disease are GABA-derivative antispasmotic agents used effectively to
control muscle spasm?
a. Muscular dystrophy
b. Parkinson's disease
c. Multiple sclerosis
d. Huntington's disease -- ANSWER--c. Multiple sclerosis
What is the FDA-approved use for belladonna?
a. Moderate to severe pain associated with ureteral spasm not responsive to
nonnarcotic analgesics
b. Irritable bowel syndrome
